Sionna Therapeutics, Inc. (SION)
3.43
-0.27
(-7.30%)
USD |
NASDAQ |
Nov 12, 16:00
3.41
-0.02
(-0.58%)
After-Hours: 20:00
Sionna Therapeutics EPS Diluted (Quarterly) : -0.7171 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.7171 |
| June 30, 2026 | -0.6619 |
| March 31, 2026 | -0.5941 |
| December 31, 2025 | -0.457 |
| September 30, 2025 | -0.4561 |
| June 30, 2025 | -0.4094 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.3738 |
| December 31, 2024 | -0.3592 |
| September 30, 2024 | -0.5766 |
| June 30, 2024 | -0.1938 |
| March 31, 2024 | -0.2685 |
| December 31, 2023 | -0.2692 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 2.561 |
| Capricor Therapeutics, Inc. | -0.7338 |
| ARS Pharmaceuticals, Inc. | -0.357 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Immunic, Inc. | -0.8021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.42M |
| Total Expenses (Quarterly) | 32.42M |
| Enterprise Value | -61.75M |
| Earnings Yield | -70.85% |
| Normalized Earnings Yield | -68.05 |